While there are no guidelines yet for circulating biomarkers in early ALS diagnosis, research on potential biomarkers, such as NfL, microRNA (miRNA), and TDP-43, in blood shows promise as prognostic indicators. This evidence concerns the gene NEFL and amyotrophic lateral sclerosis.